Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48823, USA.
J Innate Immun. 2009;1(4):376-88. doi: 10.1159/000207194. Epub 2009 Mar 4.
The use of Adenovirus (Ad)-based vectors has proven to be a useful platform for the development of gene therapy and vaccine protocols. The immunological mechanisms underlying these properties need to be identified and understood to foster safer, more efficacious use of this important gene transfer platform. Our recent studies have confirmed an important role for MyD88 dependent toll-like receptor (TLR) pathways as mediators of these responses. In this study, we confirm that TLR3, TLR4 and TRIF (TIR-domain-containing adapter-inducing interferon-beta) can also have augmentative or inhibitory roles during Ad-induced immune responses. Importantly, our studies revealed that TLR4 acts to suppress several aspects of the Ad-induced innate immune response, a finding not previously reported for this TLR in any model system. In addition, using MyD88 and TRIF double knockout mice, we demonstrate that the MyD88 and TRIF adaptor proteins can play either additive or redundant roles in mediating certain aspects of Ad vector-induced innate and adaptive immune responses. Furthering this complexity, our model system strongly suggests that non-TLR based systems must not only exist, but also have a significant role to play during Ad vector-mediated induction of adaptive immune responses.
腺病毒(Ad)载体的应用已被证明是基因治疗和疫苗方案开发的有用平台。需要确定和理解这些特性背后的免疫机制,以促进更安全、更有效的使用这一重要的基因转移平台。我们最近的研究证实,MyD88 依赖性 Toll 样受体(TLR)途径作为这些反应的介质具有重要作用。在这项研究中,我们证实 TLR3、TLR4 和 TRIF(TIR 结构域包含衔接子诱导干扰素-β)也可以在 Ad 诱导的免疫反应中发挥增强或抑制作用。重要的是,我们的研究表明 TLR4 可抑制 Ad 诱导的固有免疫反应的几个方面,这一发现以前在任何模型系统中都没有报道过这种 TLR。此外,使用 MyD88 和 TRIF 双重基因敲除小鼠,我们证明 MyD88 和 TRIF 衔接蛋白在介导 Ad 载体诱导的固有和适应性免疫反应的某些方面可以发挥相加或冗余作用。使这种复杂性进一步复杂化的是,我们的模型系统强烈表明,非 TLR 系统不仅必须存在,而且在 Ad 载体介导的适应性免疫反应诱导中也必须发挥重要作用。